Erik Schrumpf

7.3k total citations
60 papers, 3.2k citations indexed

About

Erik Schrumpf is a scholar working on Hepatology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Erik Schrumpf has authored 60 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hepatology, 27 papers in Surgery and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Erik Schrumpf's work include Liver Diseases and Immunity (41 papers), Gallbladder and Bile Duct Disorders (17 papers) and Liver Disease Diagnosis and Treatment (16 papers). Erik Schrumpf is often cited by papers focused on Liver Diseases and Immunity (41 papers), Gallbladder and Bile Duct Disorders (17 papers) and Liver Disease Diagnosis and Treatment (16 papers). Erik Schrumpf collaborates with scholars based in Norway, Sweden and United Kingdom. Erik Schrumpf's co-authors include Kirsten Muri Boberg, Tom H. Karlsen, O. Fausa, K. Elgjo, Gideon M. Hirschfield, Roger W. Chapman, Ansgar W. Lohse, Michael P. Manns, Kristian Bjøro and O. P. F. Clausen and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Erik Schrumpf

59 papers receiving 3.1k citations

Peers

Erik Schrumpf

HEPAT

SURGE

EPIDE

PRM

GENET

D Alagille France

Mette Vesterhus Norway

John Karani United Kingdom

Terry L. Gramlich United States

P. Carucci Italy

Nobuhiko Taniai Japan

Puja Sakhuja India

Alessandro Musso Italy

Marshall Kaplan United States

Paolo Muratori Italy

D Alagille France

Erik Schrumpf

1.8k ×0.8

HEPAT

2.6k ×1.6

SURGE

1.3k ×0.9

EPIDE

1.1k ×1.1

PRM

373 ×0.8

GENET

Citations per year, relative to Erik Schrumpf Erik Schrumpf (= 1×) peers D Alagille

Countries citing papers authored by Erik Schrumpf

Since Specialization

Citations

This map shows the geographic impact of Erik Schrumpf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Schrumpf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Schrumpf more than expected).

Fields of papers citing papers by Erik Schrumpf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Schrumpf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Schrumpf. The network helps show where Erik Schrumpf may publish in the future.

Co-authorship network of co-authors of Erik Schrumpf

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Schrumpf. A scholar is included among the top collaborators of Erik Schrumpf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Schrumpf. Erik Schrumpf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Trauner, Michael, Peter Fickert, Gideon M. Hirschfield, et al.. (2016). norUrsodeoxycholic acid (norUDCA) improves cholestasis in primary sclerosing cholangitis (PSC) independent of ursodeoxycholic acid (UDCA) pre-treatment and response. Hepatology. 63. 4 indexed citations

Fosby, Bjarte, Kirsten Muri Boberg, O. P. F. Clausen, et al.. (2015). Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway. Transplantation Direct. 1(9). e39–e39. 27 indexed citations

Jørgensen, Kristin Kaasen, Lina Lindström, Milada Cvancarova, et al.. (2013). Immunosuppression After Liver Transplantation for Primary Sclerosing Cholangitis Influences Activity of Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology. 11(5). 517–523. 53 indexed citations

Grzyb, Krzysztof, Knut E. A. Lundin, O. P. F. Clausen, et al.. (2011). Inflammatory bowel disease in patients with primary sclerosing cholangitis: Clinical characterization in liver transplanted and nontransplanted patients. Inflammatory Bowel Diseases. 18(3). 536–545. 100 indexed citations

Hov, Johannes R., Vasilis Kosmoliaptsis, Marita Olsson, et al.. (2011). Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis. Hepatology. 53(6). 1967–1976. 47 indexed citations

Karlsen, Tom H., Erik Schrumpf, & Kirsten Muri Boberg. (2010). Update on primary sclerosing cholangitis. Digestive and Liver Disease. 42(6). 390–400. 78 indexed citations

Karlsen, Tom H., Erik Schrumpf, & Kirsten Muri Boberg. (2010). Primary sclerosing cholangitis. Best Practice & Research Clinical Gastroenterology. 24(5). 655–666. 44 indexed citations

Vik, Erik Sebastian, Bjørn Dalhus, Tom H. Karlsen, et al.. (2009). Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma. Carcinogenesis. 30(7). 1147–1154. 41 indexed citations

Scholz, Tim, Tom H. Karlsen, Truls Sanengen, Erik Schrumpf, & Aksel Foss. (2009). Levertransplantasjon i Norge gjennom 25 år. Tidsskrift for Den norske legeforening. 129(24). 2587–2592. 7 indexed citations

10.

Karlsen, Tom H., Benedicte A. Lie, Kathrine Frey Frøslie, et al.. (2006). Polymorphisms in the Steroid and Xenobiotic Receptor Gene Influence Survival in Primary Sclerosing Cholangitis. Gastroenterology. 131(3). 781–787. 49 indexed citations

11.

Bowlus, Christopher L., Tom H. Karlsen, Ulrika Broomé, et al.. (2006). Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis. Journal of Hepatology. 45(5). 704–710. 14 indexed citations

12.

Bjøro, Kristian, Bjørn Brandsæter, Aksel Foss, & Erik Schrumpf. (2006). Liver Transplantation in Primary Sclerosing Cholangitis. Seminars in Liver Disease. 26(1). 69–79. 59 indexed citations

13.

Wiencke, Kristine, Kirsten Muri Boberg, Peter T. Donaldson, et al.. (2006). No major effect of theCD28/CTLA4/ICOSgene region on susceptibility to primary sclerosing cholangitis. Scandinavian Journal of Gastroenterology. 41(5). 586–591. 6 indexed citations

14.

Karlsen, Tom H., Jochen Hampe, Kristine Wiencke, et al.. (2006). Genetic Polymorphisms Associated With Inflammatory Bowel Disease Do Not Confer Risk for Primary Sclerosing Cholangitis. The American Journal of Gastroenterology. 102(1). 115–121. 35 indexed citations

15.

Isoniemi, Helena, Ulrika Broomé, Michael Olausson, et al.. (2004). Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. Journal of Hepatology. 40(5). 815–822. 135 indexed citations

16.

Boberg, Kirsten Muri & Erik Schrumpf. (2004). Diagnosis and treatment of cholangiocarcinoma. Current Gastroenterology Reports. 6(1). 52–59. 24 indexed citations

17.

Wiencke, Kristine, A.S. Louka, Anne Spurkland, et al.. (2004). Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients. Journal of Hepatology. 41(2). 209–214. 32 indexed citations

18.

Boberg, Kirsten Muri, Giuseppe Rocca, Thore Egeland, et al.. (2002). Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis. Hepatology. 35(3). 652–657. 61 indexed citations

19.

Wiencke, Kristine, Anne Spurkland, Erik Schrumpf, & Kirsten Muri Boberg. (2001). Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles. Hepatology. 34(4). 625–630. 67 indexed citations

20.

Zauli, Daniela, Erik Schrumpf, Cristina Crespi, et al.. (1987). An autoantibody profile in primary sclerosing cholangitis. Journal of Hepatology. 5(1). 14–18. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact